Dr. Danton Dye, DC Chiropractor Medicare: Medicare Enrolled Practice Location: 2631 Mcingvale Rd Ste 107, Hernando, MS 38632 Phone: 662-233-9020 |
Morton Chiropactic Clinic Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 55 East Commerce St., Hernando, MS 38632 Phone: 662-429-6102 Fax: 662-429-6044 |
Hernando Family Chiropractic, Llc Chiropractor Medicare: Medicare Enrolled Practice Location: 2631 Mcingvale Rd Ste 107, Hernando, MS 38632 Phone: 662-233-9020 |
Clay Robert Morton, D.C. Chiropractor Medicare: May Accept Medicare Assignments Practice Location: 55 E Commerce St, Hernando, MS 38632 Phone: 662-429-6102 Fax: 662-429-6044 |
Mid South Chiropractic Of Hernando Pllc Chiropractor Medicare: Medicare Enrolled Practice Location: 210 E Commerce St Ste 1, Hernando, MS 38632 Phone: 662-890-0012 Fax: 662-890-0522 |
Henry Health & Wellness, Llc Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 2620 Highway 51 S, Hernando, MS 38632 Phone: 662-449-7534 Fax: 662-449-7533 |
News Archive
Affymetrix, Inc. today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration to market its CytoScan Dx Assay. This assay is intended for the postnatal detection of DNA copy number variants in patients referred for chromosomal testing. CytoScan Dx Assay is designed to help physicians diagnose children's developmental and intellectual disabilities more comprehensively by enabling a high-resolution genome-wide analysis of genetic aberrations. High resolution analysis can reveal small aberrations not readily seen using traditional techniques.
News organizations help make sense of all the different moving parts of the health law - attitudes, concerns, lawsuits and business decisions - as the nation gears up for Oct. 1's launch of the health insurance exchanges.
Two members of the University of Colorado Cancer Center have received prestigious Idea Awards from the U.S. Department of Defense's Peer Reviewed Cancer Research Program.
Luna Innovations Incorporated (NASDAQ:LUNA), a company focusing on sensing & instrumentation and pharmaceutical nanomedicines, today announced that the Company has received a letter from The NASDAQ Stock Market indicating that because the bid price of the Company's common stock closed below the minimum $1.00 per share threshold set forth in NASDAQ Listing Rule 5550(a)(2) for the prior 30 consecutive business days, the Company has been provided 180 calendar days, or until March 15, 2010, to regain compliance with the minimum bid price requirement.
The transplantation unit at Jackson Memorial Hospital and the University of Miami, FL, USA has entered into a research project with the Allenex group company AbSorber. The project is a pilot study evaluating the endothelial cell cross match XM-ONE in their Living Donor program.
› Verified 5 days ago